Nueclear — Thyrocare Technologies Limited
Thyrocare Technologies Limited is a Public Non-govt company company incorporated in 2000 and based in Maharashtra, India. Thyrocare Technologies Limited operates in Activities of Military Hospital & Prison Hospitals (NIC 85110) with authorized capital of ₹100.00 Cr and paid-up capital of ₹52.90 Cr. For 2025-26, the company reported revenue of ₹774.27 Cr and profit after tax of ₹148.81 Cr. RegisterKaro's provisional Compliance Health Score for the company is 67/100 (grade C), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Nueclear - Network of PET-CT and CT scan centers providing cancer diagnostic services. Raised a total funding of $4M over 1 round from 1 investor.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Thyrocare Technologies Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +30d | filed |
| MGT-7 | FY2024-25 | 24 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +3d | filed |
| MGT-7 | FY2023-24 | 20 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +36d | filed |
| MGT-7 | FY2022-23 | 25 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Thyrocare Technologies Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 290480482 | Kotak Mahindra Bank Ltd(Bank) | ₹21.15 Cr | 12 Mar 2019 | Satisfied |
| 782825038 | HDFC Bank Ltd(Bank) | ₹8.32 Cr | 27 Jan 2020 | Open |
| 728150879 | ICICI Bank Ltd(Bank) | ₹24.88 Cr | 04 Jul 2021 | Open |
| 321670756 | Axis Bank Ltd(Bank) | ₹7.65 Cr | 27 Jan 2023 | Satisfied |
Charge IDs, lenders & amounts for Thyrocare Technologies Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2025-26 | — | ||||
| 2023-24 | — | ||||
| 2020-21 | — | ||||
| 2019-20 | — | ||||
| 2018-19 | — | ||||
| 2017-18 | — | ||||
| 2016-17 | — | ||||
| 2015-16 | — |
Detailed Financials
4 FYs| Line item | 2025-26 | 2023-24 | 2020-21 | 2019-20 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ||||
| Other income | ||||
| Total income | ||||
| Total expenses | ||||
| Profit before tax | ||||
| Profit / (Loss) after tax | ||||
| Balance sheet | ||||
| Equity / Net worth | ||||
| Borrowings | ||||
| Current liabilities | ||||
| Total liabilities | ||||
| Current assets | ||||
| Cash & equivalents | ||||
| Total assets | ||||
| Employees | — | — | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2025-26 | +13.0% | +33.0% | +12.0% | |
| Profit after Tax2025-26 | +313.0% | +72.0% | +87.0% | |
| Net Worth2023-24 | +40.0% | +7.0% | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2015-16 | — | — | — | — | — | |||
| 2016-17 | +27.02% | -16.04% | +17.43% | +16.59% | 1.05 | |||
| 2017-18 | +26.18% | +97.87% | +21.04% | +19.47% | 1.08 | |||
| 2018-19 | +25.72% | +3.92% | +20.89% | +19.52% | 0.07 | |||
| 2019-20 | — | +8.03% | — | — | — | |||
| 2020-21 | +25.25% | +18.57% | +26.89% | +22.69% | 0.18 | |||
| 2023-24 | +13.58% | +10.49% | +13.85% | +13.85% | 1.00 | |||
| 2025-26 | +19.22% | +47.76% | — | — | — |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 1 | 11,73,179 | 56.06% |
| Institutional Investors | 1 | 1,50,278 | 7.18% |
| Public & Others | 47 | 7,69,093 | 36.75% |
Promoter, institutional & public holding for Thyrocare Technologies Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
11 peersEvents & timeline
4External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.